Abstract
By focusing on the studies of primate behaviour and human neuroscience, we describe how different neurological processes are the base of proximate aspects of social-decision making. We also review the fact that distinct aspects of animal behaviour are not under conscious or abstract control and that instead they may be regulated by adaptive ´rules of thumb´. In particular, by describing the microbiota- gut-brain axis we elaborate on suggesting that microbiota has an influence on within-individual aspects of social decision making and in particular facilitating social interactions. Finally, we present comparative evidence of the role of microorganisms as modifiers of aspects of kinship, reproduction and group-members´ recognition, suggesting how microbiota also has an influence on betweenindividual aspects of decision making, which are themselves primary aspects of cooperation. In summary, we propose that modern socioeconomic choice theories may still benefit from alternative theoretical frameworks that consider the human being as a complex organism, with intrinsic constraints and capacities product of its evolutionary history, and not just as an exclusively-cognitive decision maker acting independently of its closest partners and commensals: its microbiota.
Keywords: Neuroeconomics, microbiota, probiotics, decision making process, social neurosciences.
Current Pharmaceutical Design
Title:Social Neuroeconomics: The Influence of Microbiota in Partner-Choice and Sociality
Volume: 20 Issue: 29
Author(s): Montiel-Castro, Augusto J., Baez-Yanez, Mario G. and Pacheco-Lopez Gustavo
Affiliation:
Keywords: Neuroeconomics, microbiota, probiotics, decision making process, social neurosciences.
Abstract: By focusing on the studies of primate behaviour and human neuroscience, we describe how different neurological processes are the base of proximate aspects of social-decision making. We also review the fact that distinct aspects of animal behaviour are not under conscious or abstract control and that instead they may be regulated by adaptive ´rules of thumb´. In particular, by describing the microbiota- gut-brain axis we elaborate on suggesting that microbiota has an influence on within-individual aspects of social decision making and in particular facilitating social interactions. Finally, we present comparative evidence of the role of microorganisms as modifiers of aspects of kinship, reproduction and group-members´ recognition, suggesting how microbiota also has an influence on betweenindividual aspects of decision making, which are themselves primary aspects of cooperation. In summary, we propose that modern socioeconomic choice theories may still benefit from alternative theoretical frameworks that consider the human being as a complex organism, with intrinsic constraints and capacities product of its evolutionary history, and not just as an exclusively-cognitive decision maker acting independently of its closest partners and commensals: its microbiota.
Export Options
About this article
Cite this article as:
Montiel-Castro , J. Augusto, Baez-Yanez , G. Mario and Gustavo Pacheco-Lopez, Social Neuroeconomics: The Influence of Microbiota in Partner-Choice and Sociality, Current Pharmaceutical Design 2014; 20 (29) . https://dx.doi.org/10.2174/1381612820666140130210631
DOI https://dx.doi.org/10.2174/1381612820666140130210631 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurophysiological Alterations in the Prepsychotic Phases
Current Pharmaceutical Design Physiological Roles of Neuronal Nicotinic Receptors Subtypes: New Insights on the Nicotinic Modulation of Neurotransmitter Release, Synaptic Transmission and Plasticity
Current Topics in Medicinal Chemistry Sphingosine Kinases Signalling in Carcinogenesis
Mini-Reviews in Medicinal Chemistry An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Retigabine: Could it be the Next Broad-Spectrum Antiepileptic Drug?
Current Drug Therapy Extrasynaptic GABA<sub>A</sub> Receptors in the Brainstem and Spinal Cord: Structure and Function
Current Pharmaceutical Design TRP Channels as A Newly Emerging Non-Voltage-Gated Ca2+ Entry Channel Superfamily
Current Pharmaceutical Design Lower K<sub>V</sub>7.5 Potassium Channel Subunit Expression in an Animal Model of Paroxysmal Dystonia
CNS & Neurological Disorders - Drug Targets Expanded Temporal Binding Windows in People with Mild Cognitive Impairment
Current Alzheimer Research Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety
Current Gene Therapy Visual Event-Related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease: A Literature Review
Current Alzheimer Research Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics
Current Pharmaceutical Design Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Current Pharmaceutical Design Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels
Current Molecular Pharmacology A Review of the Evidence for a Neuroendocrine Link Between Stress, Depression and Diabetes Mellitus
Current Diabetes Reviews Alzheimer’s Disease and Autistic Spectrum Disorder: Is there any Association?
CNS & Neurological Disorders - Drug Targets An <i>OTOF</i> Frameshift Variant Associated with Auditory Neuropathy Spectrum Disorder
Current Genomics Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker
Current Molecular Medicine Clinical Trials in Relapsing-Remitting Multiple Sclerosis /A New Proposal for Dealing with Basic Problems and Restrictions/
Reviews on Recent Clinical Trials